cilostazol
- Product NDC
- 71610-813
- 11-digit product format
- 716100813
- Labeler code
- 71610
- Product ID
- 71610-813_1547a408-12a9-fadd-e063-6394a90a4ce0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cilostazol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA077030
- Marketing category
- ANDA
- Marketing start
- 2022-04-12
- Substance
- CILOSTAZOL
- Active strength
- 100 mg/1
- Pharmacologic classes
- Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| N7Z035406B | CILOSTAZOL | 73963-72-1 | CILOSTAZOL |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71610-813-26 | 71610081326 | 1200 TABLET in 1 BOTTLE (71610-813-26) | 1200 tablet | 2024-04-03 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| cilostazol | Aphena Pharma Solutions - Tennessee, LLC | 2024-04-04 | HUMAN PRESCRIPTION DRUG LABEL | 1 |